Home

Leadership in Left Main Intervention

We are a pre-commercial stage private medical technology company focused on developing and commercializing percutaneous implants for the treatment of Left Main lesions. In the USA, 20% of patients diagnosed with this life-threatening disease are ineligible for surgery and no interventional option is approved. Poseidon is well positioned to produce the first device with a Left Main PC FDA indication to solve this significant unmet need.